Schedule of Warrant Activities (Details) - Warrant [Member] - USD ($) $ / shares in Units, $ in Thousands |
9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
|||
| Number of Shares, Balance | 7,083,500 | |||
| Weighted Average Exercise Price, Balance | $ 0.05 | |||
| Aggregate Intrinsic Value | [1] | $ 850 | ||
| Number of Shares, Granted | 7,083,500 | |||
| Weighted Average Exercise Price, Granted | $ 0.05 | |||
| Number of Shares, Balance | 7,083,500 | |||
| Weighted Average Exercise Price, Balance | $ 0.05 | |||
| Weighted Average Remaining Contractual Term in Years | 4 years 18 days | |||
| Aggregate Intrinsic Value Outstanding | [1] | $ 850 | ||
| Exercisable, Balance | 7,083,500 | |||
| Weighted Average Exercise Price, Exercisable | $ 0.20 | |||
| Weighted Average Remaining Contractual Term in Years, Exercisable | 3 years 10 months 6 days | |||
| Aggregate Intrinsic Value, Exercisable | [1] | $ 177 | ||
| ||||
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock non options outstanding as of the balance sheet date can be currently converted under the option plan. No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the warrant plan. No definition available.
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of non options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the warrant plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non options. No definition available.
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of warrants outstanding and currently exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of warrants outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for warrant awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|